filgotinib (GLPG0634) - Gilead
Filgotinib: Data from P2b/3 SELECTION1 trial (NCT02914522) for ulcerative colitis in Q2 2020 (Gilead) - Oct 25, 2019 - Q3 2019 Results 
P2/3 data
http://investors.gilead.com/static-files/4def9c84-f211-4174-af31-b3eef879ab29
 
Oct 25, 2019
 
 
34b168a6-ced7-49db-8d20-206f24857776.jpg